Subjective responses to amphetamine in young adults with previous mood elevation experiences
- 130 Downloads
One risk factor for alcohol and substance misuse is hypomanic experiences, or periods of mood elevation. Young people who report hypomanic states are more likely to develop bipolar disorder (BP), and BP and other mood disorders increase the risk of addiction. We recently reported that young adults with a history of mood elevation experience less subjective effects from a low dose of alcohol, which may be predictive of future alcohol use. The finding with alcohol raised the question of whether this dampened response to a drug also applies to other drugs, such as amphetamine.
This study assessed responses of d-amphetamine in healthy young adults with varying experiences of mood elevation, as measured by the Mood Disorders Questionnaire (MDQ).
Healthy 18–19-year-olds (N = 30) with a range of MDQ scores participated in three 4-h laboratory sessions in which they received placebo, 10 mg, or 20 mg d-amphetamine. They completed mood questionnaires and cardiovascular measures.
Individuals with higher MDQ scores reported less stimulation and euphoria after 10 mg, but not 20 mg, d-amphetamine, than individuals with lower scores. MDQ scores were not related to cardiovascular responses to the drug.
A history of mood elevation experiences or hypomania states is related to dampened response to a low dose of a psychostimulant drug, extending previous findings with dampened response to alcohol. This phenotype for mood disorders of dampened responses to drugs may contribute to risk for subsequent drug use or misuse.
KeywordsAmphetamine Bipolar disorder Hypomania Subjective effects
This research was supported by NIH grant R01DA02812 awarded to HdW. STS was supported by the NIDA Training Grant “Integrative Training in the Neurobiology of Addictive Behaviors” (T32DA043469) and DA was supported by the NIH Clinical Therapeutics Training Grant (T32GM007019).
Compliance with ethical standards
Study procedures were approved by the Institutional Review Board at the University of Chicago and were carried out in accordance with the Declaration of Helsinki.
- American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric PubGoogle Scholar
- Eysenck SBG, Eysenck HJ, Barrett P (1985) A revised version of the psychoticism scale. Personal Individ Differ 6:21–29Google Scholar
- First MB, Spitzer RL, Gibbon M, Williams JB (2012) Structured clinical interview for DSM-IV axis I disorders (SCID-I) s, clinician version, administration bookletGoogle Scholar
- Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, Chuang SZ, Elliott GR, Arnold LE, March JS, Hechtman L, Pelham WE, Swanson JM (2003) Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol 13:123–136PubMedGoogle Scholar
- Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, Lewis L, McElroy SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J (2000) Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 157:1873–1875PubMedGoogle Scholar
- Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacol 24:97–129Google Scholar
- Levey DF, Le-Niculescu H, Frank J, Ayalew M, Jain N, Kirlin B, Learman R, Winiger E, Rodd Z, Shekhar A, Schork N, Kiefer F, Wodarz N, Muller-Myhsok B, Dahmen N, Consortium G, Nothen M, Sherva R, Farrer L, Smith AH, Kranzler HR, Rietschel M, Gelernter J, Niculescu AB (2014) Genetic risk prediction and neurobiological understanding of alcoholism. Transl Psychiatry 4:e391PubMedPubMedCentralGoogle Scholar
- McNair DM (1971) Manual profile of mood states. Educational & Industrial testing service, San Diego, CAGoogle Scholar
- Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68:241–251PubMedPubMedCentralGoogle Scholar
- Overall JE, Gorham DR (1962) The brief psychiatric rating-scale. Psychol Rep 10:799–812Google Scholar
- Patel SD, Le-Niculescu H, Koller DL, Green SD, Lahiri DK, McMahon FJ, Nurnberger JI Jr, Niculescu AB 3rd (2010) Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet B Neuropsychiatr Genet 153B:850–877PubMedGoogle Scholar
- Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB (2003) The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54:573–583PubMedGoogle Scholar
- Trost S, Diekhof EK, Mohr H, Vieker H, Kramer B, Wolf C, Keil M, Dechent P, Binder EB, Gruber O (2016) Investigating the impact of a genome-wide supported bipolar risk variant of MAD1L1 on the human reward system. Neuropsychopharmacol 41:2679–2687Google Scholar
- Waxmonsky J, Pelham WE, Gnagy E, Cummings MR, O’Connor B, Majumdar A, Verley J, Hoffman MT, Massetti GA, Burrows-MacLean L, Fabiano GA, Waschbusch DA, Chacko A, Arnold FW, Walker KS, Garefino AC, Robb JA (2008) The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol 18:573–588PubMedPubMedCentralGoogle Scholar
- Weafer J, Ross TJ, O’Connor S, Stein EA, de Wit H, Childs E (2018) Striatal activity correlates with stimulant-like effects of alcohol in healthy volunteers. Neuropsychopharmacol 43:2532–2538Google Scholar
- White TL, Lott DC, de Wit H (2006) Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacol 31:1064–1074Google Scholar
- Yip SW, Doherty J, Wakeley J, Saunders K, Tzagarakis C, de Wit H, Goodwin GM, Rogers RD (2012) Reduced subjective response to acute ethanol administration among young men with a broad bipolar phenotype. Neuropsychopharmacol 37:1808–1815Google Scholar
- Yip SW, Worhunsky PD, Rogers RD, Goodwin GM (2015) Hypoactivation of the ventral and dorsal striatum during reward and loss anticipation in antipsychotic and mood stabilizer-naive bipolar disorder. Neuropsychopharmacol 40:658–666Google Scholar